Syndax Pharmaceuticals (SNDX) Interest Coverage Ratio (2020 - 2025)
Syndax Pharmaceuticals (SNDX) recorded quarterly Interest Coverage Ratio of 17338.25 in Q2 2025, up 58.6% quarter-over-quarter from 41878.5 in Q1 2025, and down 951.28% on a YoY basis from 2036.72 in Q2 2024.
Syndax Pharmaceuticals (SNDX) Interest Coverage Ratio (2020 - 2025) Analysis & Trends
Syndax Pharmaceuticals' Interest Coverage Ratio history runs 6 years deep, the most recent figure standing at 17338.25 for Q2 2025.
- In Q2 2025, Interest Coverage Ratio fell 951.28% year-over-year to 17338.25; the TTM figure through Mar 2026 stood at 55882.25 (down 977.44% YoY), while the FY2025 annual figure was 45514.0, down 113.4% from the prior year.
- Interest Coverage Ratio was 17338.25 for Q2 2025 at Syndax Pharmaceuticals, up from 41878.5 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 777.14 in Q4 2024 to a low of 41878.5 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 4689.19 across 5 years, with a median of 945.73 in 2022.
- The sharpest annual moves came in 2021 and 2024: Interest Coverage Ratio tumbled 43635.16% in 2021, then soared 162.85% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 13678.43 in 2021, then jumped by 92.85% to 977.51 in 2022, then slipped by 26.5% to 1236.59 in 2023, then jumped by 162.85% to 777.14 in 2024, then tumbled by 2331.04% to 17338.25 in 2025.
- The last three Interest Coverage Ratio figures came in at 17338.25 (Q2 2025), 41878.5 (Q1 2025), and 777.14 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Syndax Pharmaceuticals | 1.69 Bn | 1.34 Bn | 53.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -17,338.25 |
| Mar 31, 2025 | -41,878.50 |
| Dec 31, 2024 | 777.14 |
| Sep 30, 2024 | -3,894.65 |
| Jun 30, 2024 | -1,649.24 |
| Mar 31, 2024 | -913.95 |
| Dec 31, 2023 | -1,236.59 |
| Sep 30, 2023 | -805.07 |
| Jun 30, 2023 | -1,419.37 |
| Mar 31, 2023 | -1,150.38 |
| Dec 31, 2022 | -977.51 |
| Sep 30, 2022 | -20.10 |
| Jun 30, 2022 | -54.28 |
| Mar 31, 2022 | -56.62 |
| Dec 31, 2021 | -13,678.43 |
| Sep 30, 2021 | -30.87 |
| Jun 30, 2021 | -35.23 |
| Mar 31, 2021 | -43.60 |
| Dec 31, 2020 | -31.28 |
| Sep 30, 2020 | -31.26 |